For the quarter ending 2025-09-30, TYRA has $301,851K in assets. $21,342K in debts. $61,951K in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 61,951 | 98,490 | ||
| Marketable securities | 212,973 | 197,781 | ||
| Prepaid expenses and other current assets | 6,292 | 5,884 | ||
| Total current assets | 281,216 | 302,155 | ||
| Restricted cash | 1,000 | 1,000 | ||
| Property and equipment, net | 1,346 | 1,413 | ||
| Right-of-use assets | 5,699 | 5,822 | ||
| Other long-term assets | 12,590 | 11,109 | ||
| Total assets | 301,851 | 321,499 | ||
| Accounts payable | 1,991 | 2,245 | ||
| Lease liabilities, current | 456 | 441 | ||
| Accrued expenses and other current liabilities | 13,432 | 11,084 | ||
| Total current liabilities | 15,879 | 13,770 | ||
| Lease liabilities, noncurrent | 5,463 | 5,582 | ||
| Other long-term liabilities | 0 | 0 | ||
| Total liabilities | 21,342 | 19,352 | ||
| Common stock, 0.0001 par value 500,000,000 shares authorized at september 30, 2025 and december 31, 2024 53,318,198 and 50,754,262 shares issued at september 30, 2025 and december 31, 2024, respectively, and 53,318,198 and 50,749,945 shares outstanding at september 30, 2025 and december 31, 2024, respectively | 5 | 5 | ||
| Additional paid-in capital | 617,486 | 609,262 | ||
| Accumulated other comprehensive income | 442 | 436 | ||
| Accumulated deficit | -337,424 | -307,556 | ||
| Total stockholders' equity | 280,509 | 302,147 | ||
| Total liabilities and stockholders' equity | 301,851 | 321,499 | ||
Tyra Biosciences, Inc. (TYRA)
Tyra Biosciences, Inc. (TYRA)